Related content

In vitro evaluation of the astatinated chimeric monoclonal antibody U36, a potential candidate for treatment of head and neck squamous cell carcinoma

By Nestor M.   Persson M.   Dongen G.   Jensen H.   Lundqvist H.   Anniko M.   Tolmachev V.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 32, Iss. 11, 2005-11 ,pp. : 1296-1304

Springer Publishing Company

Access to resources Recommend Favorite

Proof of principle for the use of ¹¹C-labelled peptides in tumour diagnosis with PET

By Henriksen G.   Schottelius M.   Poethko T.   Hauser A.   Wolf I.   Schwaiger M.   Wester Hans-Jürgen  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 12, 2004-12 ,pp. : 1653-1657

Springer Publishing Company

Access to resources Recommend Favorite

Incidence of radiation-induced Graves’ disease in patients treated with radioiodine for thyroid autonomy before and after introduction of a high-sensitivity TSH receptor antibody assay

By Dunkelmann Simone   Wolf Ricarda   Koch Annedore   Kittner Christian   Groth Peter   Schuemichen Carl  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 10, 2004-10 ,pp. : 1428-1434

Springer Publishing Company

Access to resources Recommend Favorite

Targeting of lacZ reporter gene expression with radioiodine-labelled phenylethyl-β-d-thiogalactopyranoside

By Lee Kyung-Han   Byun Sang   Choi Joon   Paik Jin-Young   Choe Yearn   Kim Byung-Tae  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 3, 2004-03 ,pp. : 433-438

Springer Publishing Company

Access to resources Recommend Favorite

[¹¹C]Choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy

By Reske Sven  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 9, 2008-09 ,pp. : 1740-1741

Springer Publishing Company

Access to resources Recommend Favorite